Biotech Stocks To Watch Now – May 11th

AbbVie, Thermo Fisher Scientific, and Danaher are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies that develop products and technologies based on biological processes, such as pharmaceuticals, gene therapies, and diagnostic tools. Investors in these stocks often look for firms with promising drug pipelines, strong research and development capabilities, and the potential for regulatory approval and commercial success. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of AbbVie stock traded down $1.28 during trading on Friday, reaching $184.30. The company’s stock had a trading volume of 7,806,084 shares, compared to its average volume of 6,133,352. The business’s fifty day moving average price is $194.23 and its 200-day moving average price is $187.23. AbbVie has a one year low of $153.58 and a one year high of $218.66. The firm has a market cap of $326.02 billion, a price-to-earnings ratio of 76.79, a price-to-earnings-growth ratio of 1.62 and a beta of 0.56. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of TMO traded down $7.85 during trading hours on Friday, reaching $402.93. 2,318,607 shares of the company traded hands, compared to its average volume of 1,799,554. Thermo Fisher Scientific has a 1-year low of $401.75 and a 1-year high of $627.88. The stock has a market cap of $152.10 billion, a P/E ratio of 24.38, a price-to-earnings-growth ratio of 2.99 and a beta of 0.82. The stock’s fifty day moving average is $464.67 and its 200 day moving average is $514.85. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.29 and a current ratio of 1.66.

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Shares of NYSE DHR traded down $5.40 during trading hours on Friday, reaching $189.42. The stock had a trading volume of 4,535,806 shares, compared to its average volume of 3,411,207. The company has a market cap of $135.56 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The business’s fifty day moving average is $198.39 and its two-hundred day moving average is $219.21. Danaher has a twelve month low of $171.00 and a twelve month high of $281.70.